NEW YORK (GenomeWeb News) – Accelrys today reported a 2 percent uptick in revenues for the second quarter of its 2009 fiscal year, accompanied by a 25 percent dip in net profit for the period.
The scientific software firm’s revenue for the quarter ended Sept. 30, 2008, rose slightly to $20.1 million from $19.7 million for the same quarter of the previous year.
Product development costs declined 11 percent to $3.8 million from $4.3 million in the third quarter of 2007, while sales and marketing costs rose 15 percent to $8.2 million from $7.1 million.
Net income fell to $1.2 million, or $.04 per share, from $1.6 million, or $.06 per share, for the same quarter of the previous year.
As of Sept. 30, Accelrys had $70.3 million in cash, cash equivalents, and marketable securities.
Mark Emkjer, president and CEO of Accelrys, said in a statement that the company’s financial results were “in line with our expectations.”